Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials

Aziz Zaanan,Qian Shi,Julien Taieb,Steven R. Alberts,Jeffrey P. Meyers,Thomas C. Smyrk,C. Julié,Ayman Zawadi,Josep Tabernero,Enrico Mini,Richard M. Goldberg,Gunnar Folprecht,Jean-Luc Van Laethem,Karine Le Malicot,Daniel J. Sargent,Pierre Laurent-Puig,Frank A. Sinicrope

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials

2020

Aziz Zaanan
Qian Shi
Julien Taieb
Steven R. Alberts
Jeffrey P. Meyers
Thomas C. Smyrk
C. Julié
Ayman Zawadi
Josep Tabernero
Enrico Mini
Richard M. Goldberg
Gunnar Folprecht
Jean-Luc Van Laethem
Karine Le Malicot
Daniel J. Sargent
Pierre Laurent-Puig
Frank A. Sinicrope

PURPOSEThe microsatellite instability (MSI) or deficient mismatch repair (dMMR) phenotype is usually regarded as a single biologic entity, given the absence of comparative analyses regarding progno...

Keywords:

Colorectal cancer
Phenotype
Adjuvant
Oncology
Cetuximab
DNA mismatch repair
Internal medicine
Medicine
Microsatellite instability
FOLFOX
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations